We could not find any results for:
Make sure your spelling is correct or try broadening your search.
STRASBOURG, France, October 19 /PRNewswire-FirstCall/ -- Transgene (Eurolist Paris: FR0005175080) announces its cash position and net cash expenditures for the nine months ending September 30...
STRASBOURG, France, Sept. 21 /PRNewswire-FirstCall/ -- Transgene (Paris Eurolist: FR0005175080; Nasdaq: TRGNY) today announced it will voluntarily delist its American Depositary Shares ("ADSs...
STRASBOURG, France, Aug. 3 /PRNewswire-FirstCall/ -- Transgene (Eurolist Paris: FR0005175080; Nasdaq: TRGNY) announced today financial results for the first half of 2005: Condensed...
Transgene Announces Achievement of Clinical Milestone by Merck & Co., Inc. Using Transgene's Proprietary Technology STRASBOURG, France, July 21 /PRNewswire-FirstCall/ -- Transgene...
Transgene Raises Euro 34.9 Million STRASBOURG, France, July 11 /PRNewswire-FirstCall/ -- Transgene (Eurolist Paris : FR0005175080 - Nasdaq: TRGNY) announced today the results of its capital...
Transgene Announces 20-F Form Filing STRASBOURG, France, May 20 /PRNewswire-FirstCall/ -- Transgene (Nasdaq: TRGNY; Eurolist Paris: FR0005175080), announced today that its Form 20-F for...
Transgene's Therapeutic Vaccine MVA-MUC1-IL2 at ASCO: - Confirmation of Phase II Positive Data In Non Small Cell Lung Cancer STRASBOURG, France, May 17 /PRNewswire-FirstCall/ -- Transgene...
Transgene Presents Updated Positive Phase II Data of Its Therapeutic Vaccine MVA-MUC1-IL2 In Prostate Cancer at Annual ASCO Meeting STRASBOURG, France, May 16 /PRNewswire-FirstCall/ -- Transgene...
Transgene to Present at the 2nd Rodman & Renshaw Annual Global Healthcare Conference STRASBOURG, France, April 26 /PRNewswire-FirstCall/ -- Transgene (Nasdaq: TRGNY; Eurolist Paris:...
Transgene: Cash Position and Net Cash Expenditures as of March 31, 2005 STRASBOURG, France, April 13 /PRNewswire-FirstCall/ -- Transgene (Nasdaq: TRGNY; Eurolist Paris: FR0005175080) today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions